Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |